RK
Rajeev Kumar Jain
About Rajeev Kumar Jain
Data last updated:
Rajeev Kumar Jain is a Director at Synthimed Labs Private Limited (since 2025). The companies operate in Pharma. Synthimed Labs Private Limited reported revenue of ₹1,478 Cr (FY 2025). Earlier, Rajeev Kumar Jain was a Ceo at Supriya Lifescience Limited (2022–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 May 2025 | 2023 | ₹1,478 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 03 Oct 2022 | 2008 | ₹839 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajeev Kumar Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Poddar | Synthimed Labs Private Limited | Cfo | |
| Hrishikesh Dinkar Samant | 10320755 | Synthimed Labs Private Limited | Nominee Director |
| Kacharu Shivprasad Toshniwal | 10661327 | Synthimed Labs Private Limited | Ceo |
| Kacharu Shivprasad Toshniwal | Synthimed Labs Private Limited | Ceo | |
| Mrinal Chandran | 02578553 | Synthimed Labs Private Limited | Nominee Director |
| Renu Pandey | Synthimed Labs Private Limited | Company Secretary | |
| Shitij Ramesh Kale | 08593079 | Synthimed Labs Private Limited | Nominee Director |
| Srinivas Nagalla | 10898426 | Synthimed Labs Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Kumar Jain
Rajeev Kumar Jain currently holds 1 directorship: Synthimed Labs Private Limited (Director, since 19 May 2025, revenue ₹1,478 Cr (FY 2025)).
Rajeev Kumar Jain was first appointed on 03 Oct 2022 as Ceo at Supriya Lifescience Limited. The most recent appointment on record is 19 May 2025 at Synthimed Labs Private Limited.
Rajeev Kumar Jain held 1 earlier board appointment: Supriya Lifescience Limited (Ceo, 03 Oct 2022 to 14 Jun 2024).
The current boards of Rajeev Kumar Jain's companies include Ashish Poddar (Synthimed Labs Private Limited), Hrishikesh Dinkar Samant (Synthimed Labs Private Limited), Kacharu Shivprasad Toshniwal (Synthimed Labs Private Limited), Kacharu Shivprasad Toshniwal (Synthimed Labs Private Limited), Mrinal Chandran (Synthimed Labs Private Limited), Renu Pandey (Synthimed Labs Private Limited), among others.